Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Zai Lab logo — Delivering innovative, transformational outcomes to patients...

Zai Lab

Delivering innovative, transformational outcomes to patients around the world

Founded 2014 China China 529 employees IPO Total: $2.59B Biotechnology, Health Care +1

General Information

Company Name Zai Lab
Founded Year 2014
Location China China +8
Employees 529
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage IPO
Social

Get notified when Zai Lab moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Zai Lab

Zai Lab, founded in 2014, is a dynamic, commercial-stage biopharmaceutical company headquartered in China, with operations extending to the United States. The company's focus lies in the biotechnology, healthcare, and pharmaceutical industries, dedicated to discovering and bringing to market cutting-edge products that target critical medical needs in oncology, autoimmune disorders, infectious diseases, and neurological disorders.

Adhering to their slogan, "Delivering innovative, transformational outcomes to patients around the world," Zai Lab aims to impact global health positively, aspiring to reach one million patients by 2030. Their strategic capabilities promise transformative commercial outcomes, underpinned by a strong research and development ethos.

Their latest investment move was a Post IPO Debt round on 01 October 2025, secured from Industrial Bank. This indicates strong financial backing and investor confidence in their innovation-driven mission and potential for market growth.

Taxonomy: biopharmaceuticals, oncology, autoimmune disorders, infectious diseases, neurological disorders, drug development, transformative medicines, global partnerships, clinical production, commercial production, regulatory environment, in-house manufacturing, pipeline expansion, biopharma commercialization, academic collaborations

Services & Products

Drug Discovery
Product Development
Manufacturing
Commercialization
Clinical Trials

Target Customers

Patients with Unmet Medical Needs Healthcare Providers Biopharmaceutical Partners

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Debt •••••• 1 •••• •••• 01 Oct 2025
Post Ipo Equity •••••• 1 •••• •••• 01 Jan 2025
Private Placement Vc •••••• - 01 Apr 2021
IPO •••••• - 01 Sep 2020
Post Ipo Equity •••••• - 01 Jan 2020

View All 11 Funding Rounds

Zai Lab Alternatives & Competitors

View All Alternatives
Zai Lab vs
City Sounds of NY- Speech-Language Development Center, Inc.
City Sounds of NY- Speech-Language Development Center, Inc.

"Dedicated to making a child's voice is heard"

73 employees
Zai Lab vs
The Ranch TN
The Ranch TN United States

The Ranch provides a highly effective, one-of-a-kind recovery experience for men and women strugglin...

31 employees
Care Economy, Health Care
Compare Zai Lab vs The Ranch TN
Zai Lab vs
Connected Speech Pathology
Connected Speech Pathology United States

Online assessments & treatment for speech, language, communication, & voice disorders for adults & c...

8 employees
Health Care
Compare Zai Lab vs Connected Speech Pathology
Also compare with: Zai Lab vs Moreland Ear Nose & Throat Moreland Ear Nose & Throat View all alternatives

FAQ About Zai Lab

Delivering innovative, transformational outcomes to patients around the world
Zai Lab was founded in 2014.
Zai Lab is headquartered in China.
Zai Lab operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Zai Lab has approximately 529 employees.
Zai Lab has completed 11 funding rounds, raising a total of $2.59B. The latest funding stage is IPO.
Zai Lab offers: Drug Discovery, Product Development, Manufacturing, Commercialization, Clinical Trials.
Top alternatives and competitors to Zai Lab include City Sounds of NY- Speech-Language Development Center, Inc., The Ranch TN, Connected Speech Pathology, Moreland Ear Nose & Throat, Speech Academy LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zai Lab and City Sounds of NY- Speech-Language Development Center, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Zai Lab and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy